Qingyu Yao

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Junsheng Xue · 4 shared papers, 2019–2025 · strength 0.63
   • Paper Longitudinal and time-to-event modeling for the survival of advanced pancreatic ductal adenocarcinoma patients. DOI 10.1038/s41401-024-01403-8↗
   • Paper An integrated PK/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancr… DOI 10.1038/s41401-022-00960-0↗
   • Paper Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocar… DOI 10.1016/j.lfs.2020.118302↗
2. Tianyan Zhou · 4 shared papers, 2019–2025 · strength 0.55
   • Paper Longitudinal and time-to-event modeling for the survival of advanced pancreatic ductal adenocarcinoma patients. DOI 10.1038/s41401-024-01403-8↗
   • Paper Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and… DOI 10.1016/j.xphs.2019.10.035↗
   • Paper Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocar… DOI 10.1016/j.lfs.2020.118302↗
3. Ye Yao · 4 shared papers, 2019–2023 · strength 0.48
   • Paper An integrated PK/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancr… DOI 10.1038/s41401-022-00960-0↗
   • Paper Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and… DOI 10.1016/j.xphs.2019.10.035↗
   • Paper Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocar… DOI 10.1016/j.lfs.2020.118302↗
4. Jun Zhou · 2 shared papers, 2023–2025 · strength 0.44
   • Paper Longitudinal and time-to-event modeling for the survival of advanced pancreatic ductal adenocarcinoma patients. DOI 10.1038/s41401-024-01403-8↗
   • Paper An integrated PK/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancr… DOI 10.1038/s41401-022-00960-0↗
5. Chunyi Hao · 3 shared papers, 2019–2020 · strength 0.30
   • Paper Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and… DOI 10.1016/j.xphs.2019.10.035↗
   • Paper Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocar… DOI 10.1016/j.lfs.2020.118302↗
   • Paper N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1… DOI 10.1016/j.taap.2019.114789↗
6. Hong Su · 3 shared papers, 2019–2020 · strength 0.30
   • Paper Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and… DOI 10.1016/j.xphs.2019.10.035↗
   • Paper Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocar… DOI 10.1016/j.lfs.2020.118302↗
   • Paper N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1… DOI 10.1016/j.taap.2019.114789↗
7. Tianyan Zhou · 1 shared paper, 2023 · strength 0.18
   • Paper An integrated PK/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancr… DOI 10.1038/s41401-022-00960-0↗
8. Can Cui · 1 shared paper, 2020 · strength 0.11
   • Paper Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocar… DOI 10.1016/j.lfs.2020.118302↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.